<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">714</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"/><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>ANAGEN EFFLUVIUM - A REVIEW&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>hashikant</surname><given-names>S</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mallashetty</surname><given-names>Nagaraj</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>21</day><month>11</month><year>2014</year></pub-date><volume>)</volume><issue/><fpage>47</fpage><lpage>49</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Anagen effluvium is a type of hair loss that follows the administration of chemotherapeutic drugs, radiation treatment and various chemical agents. It is characterized by hair breakage rather than hair loss. Hair shafts break at about the same time when the thin portion reaches the scalp surface. The hair loss in anagen effluvium is quite disturbing to patients and their family members. Dermatologists have little experience with anagen effluvium.&#13;
</p></abstract><kwd-group><kwd>Anagen effluvium</kwd><kwd> Diffuse hair loss</kwd></kwd-group></article-meta></front></article>
